161 related articles for article (PubMed ID: 2690972)
21. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
22. Aminoglutethimide in the treatment of metastatic breast cancer.
Troner MB
Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
[TBL] [Abstract][Full Text] [Related]
23. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
[TBL] [Abstract][Full Text] [Related]
24. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG
Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078
[TBL] [Abstract][Full Text] [Related]
25. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
Brufman G; Biran S
Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
[TBL] [Abstract][Full Text] [Related]
26. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
[TBL] [Abstract][Full Text] [Related]
27. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Allegra JC
Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
[TBL] [Abstract][Full Text] [Related]
28. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
29. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer; 1982 Dec; 50(11):2265-8. PubMed ID: 6754061
[No Abstract] [Full Text] [Related]
31. Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Leitzel K; Teramoto Y; Konrad K; Chinchilli VM; Volas G; Grossberg H; Harvey H; Demers L; Lipton A
J Clin Oncol; 1995 May; 13(5):1129-35. PubMed ID: 7738618
[TBL] [Abstract][Full Text] [Related]
32. Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
Boccardo F; Rubagotti A; Amoroso D; Mesiti M; Romeo D; Caroti C; Farris A; Cruciani G; Villa E; Schieppati G; Mustacchi G;
J Clin Oncol; 2001 Nov; 19(22):4209-15. PubMed ID: 11709564
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
Brufman G
Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
[TBL] [Abstract][Full Text] [Related]
34. Megestrol acetate in advanced breast carcinoma.
Espie M
Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
[TBL] [Abstract][Full Text] [Related]
35. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective study.
Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Bacon LD; Rossof AH; Economou SG
Cancer Treat Rep; 1983; 67(7-8):717-20. PubMed ID: 6871887
[TBL] [Abstract][Full Text] [Related]
37. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
[TBL] [Abstract][Full Text] [Related]
38. Metastatic breast cancer: preliminary results with oral hormonal therapy.
Allegra JC; Bertino J; Bonomi P; Byrne P; Carpenter J; Catalano R; Creech R; Dana B; Durivage H; Einhorn L
Semin Oncol; 1985 Dec; 12(4 Suppl 6):61-4. PubMed ID: 3909420
[TBL] [Abstract][Full Text] [Related]
39. Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen.
Buzdar AU; Powell KC; Legha SS; Blumenschein GR
Cancer; 1982 Nov; 50(9):1708-12. PubMed ID: 6180820
[TBL] [Abstract][Full Text] [Related]
40. Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer.
Sutherland CM; Muchmore JH; Carter RD
South Med J; 1985 Aug; 78(8):987-9. PubMed ID: 4023793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
